Christopher DelNagro

Affiliations

F. Hoffmann-La Roche Ltd, Zurich, Switzerland.

ORCID: 0000-0002-6659-9154

Publications (1)

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research

Avec: Solange Peters , Eric Angevin , Teresa Alonso-Gordoa , Kristoffer Rohrberg , Ignacio Melero , Begoña Mellado , Jose Luis Perez-Gracia , Josep Tabernero , Celine Adessi , Christophe Boetsch , Carl Watson , Joseph Dal Porto , David Dejardin , Christopher DelNagro , Valeria Nicolini , Stefan Evers , Christian Klein , Barbara Leutgeb , Pavel Pisa , Eva Rossmann , José Saro , Pablo Umana , Jehad Charo , Volker Teichgräber , Neeltje Steeghs

Réseau de co-auteurs

Solange Peters 1 collaboration

Eric Angevin 1 collaboration

Teresa Alonso-Gordoa 1 collaboration

Kristoffer Rohrberg 1 collaboration

Ignacio Melero 1 collaboration

Begoña Mellado 1 collaboration

Jose Luis Perez-Gracia 1 collaboration

Josep Tabernero 1 collaboration

Celine Adessi 1 collaboration

Christophe Boetsch 1 collaboration

Carl Watson 1 collaboration

Joseph Dal Porto 1 collaboration

David Dejardin 1 collaboration

Valeria Nicolini 1 collaboration

Stefan Evers 1 collaboration

Christian Klein 1 collaboration

Barbara Leutgeb 1 collaboration

Pavel Pisa 1 collaboration

Eva Rossmann 1 collaboration

José Saro 1 collaboration

Pablo Umana 1 collaboration

Jehad Charo 1 collaboration

Volker Teichgräber 1 collaboration

Neeltje Steeghs 1 collaboration